New cancer clinical trial: Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer

Published on: July 26, 2018 at 12:00PM
Conditions:   Bladder Urothelial Carcinoma;   Stage IV Bladder Cancer AJCC v8;   Stage IVA Bladder Cancer AJCC v8;   Stage IVB Bladder Cancer AJCC v8
Interventions:   Biological: Durvalumab;   Radiation: External Beam Radiation Therapy;   Biological: Tremelimumab
Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/2mKVozx